Rare diseases
Investigational molecules
Locations
Back to Hungary110 clinical trials in Gyongyos, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
A Study of fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.
HungaryStudy comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer
HungaryStudy of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments
HungaryStudy comparing QL2107 and pembrolizumab in patients with resected non-small cell lung cancer receiving adjuvant therapy
HungarySafety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder
HungaryEvaluating NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder Who Are Not Responding Adequately to Current Therapy
HungaryHungaryStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
HungaryStudy comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer
HungaryStudy Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer
HungaryStudy of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer's disease
HungaryStudy on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments
HungaryThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for non-small cell lung cancer (NSCLC) and chronic respiratory conditions, with multiple trials evaluating new immunotherapy combinations and targeted therapies.
Several trials are exploring combination therapies to improve patient outcomes in advanced stages of lung cancer.
Comprehensive studies on inflammatory and autoimmune disorders, including psoriasis and inflammatory bowel diseases, testing novel therapeutic approaches.
Multiple trials are evaluating new biological therapies for moderate to severe cases of these conditions.
Innovative studies targeting heart failure prevention and cardiovascular disease management, with a focus on reducing major adverse cardiac events.
Research includes novel therapeutic combinations and preventive strategies for high-risk patients.
Clinical research focusing on Alzheimer's Disease and associated conditions, particularly investigating treatments for psychosis symptoms.
Trials are evaluating new therapeutic approaches for managing neuropsychiatric symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
